Cronos Group Net Profit Margin 2017-2025 | CRON

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Cronos Group net profit margin from 2017 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Cronos Group net profit margin from 2017 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$69.6B
Zoetis (ZTS)	$67.5B
Daiichi Sankyo, - (DSNKY)	$48.8B
Takeda Pharmaceutical (TAK)	$48.2B
BeOne Medicines - (ONC)	$35B
Sandoz Group AG (SDZNY)	$26.3B
Summit Therapeutics (SMMT)	$19.5B
Merck (MKKGY)	$16.7B
Shionogi (SGIOY)	$14.9B
United Therapeutics (UTHR)	$14.2B
Neurocrine Biosciences (NBIX)	$13.2B
Orion OYJ (ORINY)	$11.2B
IPSEN (IPSEY)	$10.6B
Eisai (ESAIY)	$9.2B
Madrigal Pharmaceuticals (MDGL)	$8.7B
Corcept Therapeutics (CORT)	$7.6B
Grifols, S.A (GRFS)	$7.3B
Ionis Pharmaceuticals (IONS)	$6.9B
Stevanato Group S.p.A (STVN)	$6.8B
Hikma Pharmaceuticals Plc (HKMPF)	$5.4B
Ono Pharmaceutical (OPHLF)	$5.4B
Soleno Therapeutics (SLNO)	$3.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.9B
Crinetics Pharmaceuticals (CRNX)	$2.8B
Hypermarcas (HYPMY)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.4B
Ocular Therapeutix (OCUL)	$2.1B
Endo (NDOI)	$1.8B